Syntec Optics receives nearly $4M in life sciences purchase orders
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/24/2026
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
- Americold to wind down Ahold Delhaize facilities, take $305M charge
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Did Google and Tesla just break AI trade’s bull case?
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
- Matador Resources to acquire Paloma Permian for $1.275B
Syntec Optics (Nasdaq: OPTX) Secures over $4M in New BioMed Orders Across Diversified Life Sciences Platforms
June 22, 2026 8:53 AM EDTROCHESTER, NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- Syntec Optics (Nasdaq: OPTX), a leading provider of mission-critical technologies for vibrant end-markets - defense tech, space tech, and biomed tech today announced it received nearly $4 million in U.S. life sciences purchase orders.Â
As the quality of healthcare in the U.S. advances, Syntec Optics is playing a pivotal role in providing the high-precision optical products required for existing and next-generation technologies.Â
Building on the previously announced $4.6 million in orders for laser blood analysis optics used in nearly every leading clinic and hospital,... More
